HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael W Dryden Selected Research

Methoprene

12/2013Evaluation of indoxacarb and fipronil (s)-methoprene topical spot-on formulations to control flea populations in naturally infested dogs and cats in private residences in Tampa FL. USA.
1/2013Assessment of owner-administered monthly treatments with oral spinosad or topical spot-on fipronil/(S)-methoprene in controlling fleas and associated pruritus in dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael W Dryden Research Topics

Disease

13Flea Infestations
07/2020 - 04/2012
7Pruritus (Itching)
07/2020 - 01/2013
4Atopic Dermatitis (Atopic Eczema)
05/2019 - 01/2016
2Dermatitis
05/2019 - 01/2019
2Hypersensitivity (Allergy)
05/2019 - 01/2019
1Skin Diseases (Skin Disease)
01/2016
1Tick Infestations
01/2004
1Cysts
02/2002
1Giardiasis
02/2002

Drug/Important Bio-Agent (IBA)

6spinosadIBA
05/2019 - 09/2012
4A1443 compoundIBA
07/2020 - 07/2015
4Flavin-Adenine Dinucleotide (FAD)IBA
05/2019 - 01/2016
3selamectinIBA
07/2020 - 03/2013
2sarolanerIBA
07/2020 - 08/2017
2lotilanerIBA
05/2019 - 01/2019
2fipronilIBA
12/2013 - 01/2013
2indoxacarbIBA
12/2013 - 05/2013
2MethopreneIBA
12/2013 - 01/2013
1afoxolanerIBA
01/2016
1flumethrinIBA
01/2016
1imidaclopridIBA
01/2016
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1milbemycin oxime (Interceptor)IBA
03/2013
1AcaricidesIBA
01/2004
1Praziquantel (Biltricide)FDA Link
02/2002
1PyrantelIBA
02/2002
1febantelIBA
02/2002
1VaccinesIBA
02/2002
1Zinc SulfateFDA Link
02/2002
1AntigensIBA
02/2002

Therapy/Procedure

1Topical Administration
04/2012
1Aftercare (After-Treatment)
02/2002
1Duration of Therapy
02/2002